Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Apoptosis ; 5(5): 403-11, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11256881

RESUMEN

OBJECTIVE: Cell death is generally classified into two large categories: apoptosis, which represents active, physiological programmed cell death, and necrosis, which represents passive cell death without underlying regulatory mechanisms. Apoptosis plays an important role in tissue homeostasis and its role in endothelium integrity can be influenced by the functional status of endothelial cells. Homocysteine, a sulfated amino-acid product of methionine demethylation, is an independent risk factor for vascular disease (arterial and venous thombosis). Our goal was to investigate the thiol-derivatives effect on the endothelial cell apoptosis. METHODS: Three parameters were measured: mitochondrial membrane potential using DiOC6(3) as the probe, DEVDase activation, and phosphatidylserine exposure on the cell surface with fluorosceinated annexin V labeling which allows apoptosis to be distinguished from necrosis. RESULTS: Homocysteine-thiolactone induced endothelial cell apoptosis in a concentration-dependent manner (range: 50-200 microM), independently of the caspase pathway. Only homocysteine-thiolactone, among the thiol derivatives tested, induced apoptosis. Apoptosis was not influenced by the serum concentration in culture medium, suggesting that the observed apoptotic process could occur in vivo. None of the inhibitors used (e.g., leupeptin, fumosinin B1, catalase, or z-VAD-fmk) was able to prevent homocysteine-induced apoptosis of vascular endothelial cells. CONCLUSION: The apoptosis of vascular endothelial cells induced by high concentration of homocysteine-thiolactone might be one step atherosclerotic cardiovascular disease, and contribute to its complication.


Asunto(s)
Apoptosis/efectos de los fármacos , Caspasas/fisiología , Endotelio Vascular/citología , Endotelio Vascular/efectos de los fármacos , Homocisteína/análogos & derivados , Homocisteína/farmacología , Apoptosis/fisiología , Carbocianinas , Muerte Celular/efectos de los fármacos , Muerte Celular/fisiología , Línea Celular , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Medios de Cultivo , Relación Dosis-Respuesta a Droga , Endotelio Vascular/enzimología , Colorantes Fluorescentes , Humanos , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/fisiología , Mitocondrias/efectos de los fármacos , Mitocondrias/fisiología , Péptido Hidrolasas/metabolismo , Fosfatidilserinas/metabolismo , Proteínas/metabolismo , Proteínas/farmacología
2.
Br J Haematol ; 107(2): 300-2, 1999 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-10583215

RESUMEN

In pathological conditions such as sickle cell disease, falciparum malaria and diabetes, an abnormal adherence of erythrocytes to endothelium is concomitant with loss of phospholipid asymmetry resulting in phosphatidylserine (PS) exposure. We have investigated the involvement of PS in this interaction by studying adhesion of human erythrocytes, treated with Ca2+-ionophore A23187 in combination with N-ethylmaleimide, to human umbilical vein endothelial cells in a flow-based assay. Results showed that erythrocytes which exposed PS, massively adhered to HUVEC in a Ca2+-dependent manner. This adhesion was inhibited by PS liposomes and by annexin V, giving clear evidence of the PS dependence of these interactions.


Asunto(s)
Endotelio Vascular/fisiología , Eritrocitos/fisiología , Fosfatidilserinas/fisiología , Calcimicina/farmacología , Adhesión Celular/efectos de los fármacos , Adhesión Celular/fisiología , Células Cultivadas , Relación Dosis-Respuesta a Droga , Etilmaleimida/farmacología , Citometría de Flujo , Humanos , Ionóforos/farmacología
4.
Haemostasis ; 26 Suppl 4: 177-81, 1996 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8979122

RESUMEN

P-selectin is an endothelial adhesion molecule involved in the initial step of the neutrophil recruitment. We investigated the effect of hypoxia (95% N2, 5% CO2) and of hypoxia-reoxygenation (95% air, 5% CO2) on the expression of P-selectin by human umbilical vein endothelial cells (HUVEC). P-selectin expression was detected by immunolabelling and quantified by flow cytometric analysis. Our data indicate that hypoxia induces an increase in P-selectin expression with a maximum reached after 90 minutes. A hypoxic exposure of 90 minutes results in a highly significant increase compared to normoxia (p < 0.001, n = 13). Furthermore, when a reoxygenation period follows 90 minutes of hypoxia, the initially elevated levels of P-selectin are dramatically enhanced with a maximum obtained after 60 minutes of reoxygenation.


Asunto(s)
Hipoxia de la Célula/genética , Endotelio Vascular/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Oxígeno/farmacología , Selectina-P/biosíntesis , Células Cultivadas , Endotelio Vascular/citología , Humanos , Isquemia/metabolismo , Neutrófilos/metabolismo , Selectina-P/genética , Reperfusión , Venas Umbilicales
5.
Haemostasis ; 26 Suppl 4: 182-8, 1996 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8979123

RESUMEN

In hypoxia/ischaemia and ischaemia/reperfusion, human neutrophils are likely to play an important role in the development of endothelial cell damage in the microcirculation. Buflomedil hypochloride improves the capillary perfusion in such related situations, evoking a possible effect upon neutrophils. Using in vitro models of cell adhesion, buflomedil decreased 100% of histamine related neutrophil adhesion (flow system) and partially inhibited adhesion after IL-1-4 hours (flow and stable systems). Hypoxia induced neutrophil adhesion (4 hours) was also reduced by buflomedil, which decreased the expression of P-selectin at the surface of endothelial cells. As adenosine (NECA) exhibited the same results in hypoxia and theophylline inhibited them, such results support an action of buflomedil presumably via the A2 receptor.


Asunto(s)
Antagonistas de Receptores Adrenérgicos alfa 2 , Antagonistas Adrenérgicos alfa/farmacología , Hipoxia de la Célula , Endotelio Vascular/efectos de los fármacos , Inflamación/patología , Neutrófilos/efectos de los fármacos , Pirrolidinas/farmacología , Adenosina/análogos & derivados , Adenosina/farmacología , Adenosina-5'-(N-etilcarboxamida) , Adhesión Celular/efectos de los fármacos , Células Cultivadas , Citocinas/metabolismo , Endotelio Vascular/citología , Humanos , Molécula 1 de Adhesión Intercelular/biosíntesis , Interleucina-1/farmacología , Selectina-P/biosíntesis , Teofilina/farmacología , Venas Umbilicales
6.
Pathol Biol (Paris) ; 42(4): 297-304, 1994 Apr.
Artículo en Francés | MEDLINE | ID: mdl-7808782

RESUMEN

Cefpirome (CPO) is a new parenteral cephalosporin with a wide antibacterial spectrum. In order to explore the possibility of using CPO in late pregnancy, we studied its placental transfer in vitro in a model of human placenta infusion. Mother-to-foetus in vitro transfer of CPO is high, similar to that of amoxicillin, with a placental clearance index of 0.20. A pharmacokinetic simulation based upon this result and data from literature suggests that CPO concentrations in foetal blood and amniotic fluid should be appropriate for the treatment of severe materno-foetal infections in late pregnancy. These preliminary results need to be confirmed by in vivo pharmacokinetic and clinical studies before recommending the use of CPO in late pregnancy.


Asunto(s)
Infecciones Bacterianas/prevención & control , Cefalosporinas/farmacología , Intercambio Materno-Fetal/efectos de los fármacos , Antipirina/sangre , Cefalosporinas/farmacocinética , Cefalosporinas/uso terapéutico , Femenino , Humanos , Recién Nacido , Embarazo , Complicaciones Infecciosas del Embarazo , Cefpiroma
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA